Alkeran
information and resources from the National Cancer Institute
Alkeran
(Other name for: melphalan)
melphalan, L-PAM GlaxoSmithKline Jan 17 1964
melphalan, L-PAM
Systemic administration for palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate.
GlaxoSmithKline Nov 18 1992
|
|
|
|
news articles
Celgene Corporation Reports Strong Operating, Regulatory and ... Nov 3, 2005
PR Newswire (press release), Abnormality Enrolling Rapidly in Europe - Significant Number of Presentations on Clinical Data for REVLIMID(R), THALOMID(R), ACTIMID(TM), ALKERAN(R) as Single ...
|
|
